Monday, 15 July 2013

Explaination for hemoperitoneum in abruptio placenta

If you do KB count,  it  will be normal as most of the blood is escaped into the peritoneum.  So one can have masssive abruption and almost a dead baby with normal Kleihauer count.

Saturday, 13 July 2013

Preterm rupture of membranes at 28 weeks – Management

  • In women with preterm PROM remote from term, 50% will go into labor within 24 to 48 hours and 70% to 90% within 7 days. Women with preterm PROM at 24 to 28 weeks of gestation are likely to have a longer latency period than those with preterm PROM closer to term.
  • Degree of oligohydramnios. The more severe the degree of oligohydramnios, the shorter the latency period.
  • Severe oligohydramnios may represent a larger hole in the membranes or evidence of early fetal compromise with diminished
    urine output
  • Digital cervical examinations also cause an average nine-day decrease in the latent period. Therefore do not do digital examination

  • Sonographic myometrial thickness. Evidence of excessive thinning of the myometrium in nonlaboring women with preterm PROM ( 12 mm) as measured by transabdominal ultrasound has been associated with a shorter latency interval
  • Evidence of pregnancy complications (such as intra-amniotic infection, placental abruption, or active labor) or nonreassuring fetal testing (previously referred to as fetal distress) will lead to early delivery and a shortened latency interval.
The fetal membranes serve as a barrier to ascending infection. Once the membranes rupture, both the mother and fetus are at risk of infection and of other complications.

Monday, 8 July 2013

Multiparous woman with a non-progress of labour (Obstructed labour)

Signs of Obstructed labour in a Multiparous woman at term
1. When the history was dug deeper,  it is usually  apparent that woman is contacting for 2-3 days.  So do not take admission to labour ward as the onset of labour.  The actual labour may have started few days ago.
2. Sunken eyes because of labour pains and dehydration and dehydration.
3. Urinary ketones (2+ and above)
4. Sub-umbilical flattening and evident bladder bulge. This is classical of  occipitoposterior position causing obstrction of labour.  Baby's sinciput hitching against pubic symphysis causing urethral swelling and swollen bladder.
5. If you scan such a woman, you will see star gazing fetus.
6. Occasionally there is presence of Bandl's ring.

Thursday, 4 July 2013

Mistakes people do when confronted with Shoulder dystocia

When confronted with shoulder dystocia, doctors and midwives do all sorts of mistakes. This is a situation where split second accurate decisions are required. These correct or incorrect decisions do account for the final clinical outcome.


  1. 1. The common mistake done is the belief that, just pulling the baby's head will effect the shoulder delivery. This is totally wrong.
  2.  Sinking feeling in the heart of the acoucher.
  3.  Not knowing which maneuver to do first. In the end, not doing any one maneuver properly.
  4.  Some health professionals also feel that they are going to loose the job whilst all of this is going on
  5. It does not matter, which maneuver you select to do first, whatver you do, do it correctly.
  6. write what time the head was born and what time the baby's body was born
  7. Which way baby was facing when the head came out
  8. Estimate the blood loss correctly by weighing the swabs, and do not do eyeball estimation of blood loss.
  9.  Rule out third and fourth degree tears.
  10.  Debrief the mother to say how badly your shoulders and arms are hurting to get the baby's shoulders out safely.

Wednesday, 3 July 2013

Resistant Hyperemesis Gravidarum Management

If symptoms so out of control refer patient to Gastroenterologists for consideration of Oesophago-gastroduodenoscopy. Rule out gastric or duodenal ulcer dyspepsia.


Perform liver and gall bladder USS to rule out gall stones and liver pathology.

One can consider following,

1. Omeprazole 40mg OD

2. Regular cyclizine 50 PO/IV TDS

3. Amitriptyline 10mg OD

4. Buscopan 10 mg IM TDS

5. Magnesium Tricylicate 10mls PO TDS

6. Ranitidine 50mg IV TDS

7. Folic Acid 5mg OD

8. Thiamine 50mg PO OD. (Pabrinex)

Weekly weight monitoring, refer patient to dietitian.

But if patients’ vomiting is still continuing, I would try Ondansetron before steroids 4mg TDS and then 8mg TDS if some help.

If no help one could consider Hydrocortisone 100mg intravenous twice a day for 3 doses. If no improvement, STOP.

If symptoms improve, convert to oral Prednisolone 40 mg OD and continue for 5 days before reducing by 5 mg every week until symptoms recur and then hold at minimum dose

Intolerable Morning Sickness Management

If symptoms so out of control refer patient to Gastroenterologists for consideration of Oesophago-gastroduodenoscopy. Rule out gastric or duodenal ulcer dyspepsia.


Perform liver and gall bladder USS to rule out gall stones and liver pathology.



One can consider following,

1. Omeprazole 40mg OD

2. Regular cyclizine 50 PO/IV TDS

3. Amitriptyline 10mg OD

4. Buscopan 10 mg IM TDS

5. Magnesium Tricylicate 10mls PO TDS

6. Ranitidine 50mg IV TDS

7. Folic Acid 5mg OD

8. Thiamine 50mg PO OD. (Pabrinex)

Weekly weight monitoring, refer patient to dietitian.

But if patients’ vomiting is still continuing, I would try Ondansetron before steroids 4mg TDS and then 8mg TDS if some help.

If no help one could consider Hydrocortisone 100mg intravenous twice a day for 3 doses. If no improvement, STOP.

If symptoms improve, convert to oral Prednisolone 40 mg OD and continue for 5 days before reducing by 5 mg every week until symptoms recur and then hold at minimum dose

Sunday, 30 June 2013

Systemic lupus erythematosus in Pregnancy

Systemic lupus erythematosus in Pregnancy

  • SLE is known to increase the risk of spontaneous miscarriage; it can also cause fetal growth restriction and increased rates of sudden intrauterine death, pre-eclampsia and preterm delivery
Pre-pregnancy counselling :

  • The presence of anti-Ro/La and 
    antiphospholipid antibodies should  be determined. 
    These antibodies are associated with congenital heart block 
    and neonatal cutaneous lupus syndrome. 
    Antiphospholipid 
    antibodies are present in about 30% of women with SLE and 
    are associated with arterial and venous thrombosis, recurrent 
    miscarriage, fetal growth restriction, fetal loss and preterm 
    delivery due to uteroplacental insufficiency.
  • Quiescent disease, without associated antiphospholipid syndrome (APS), hypertension or renal involvement the risks of miscarriage/stillbirth and fetal growth restriction are not significantly increased
  • The risk of miscarriage and stillbirth in pregnancies complicated by lupus varies in the literature from 6–35% and from 0–22%
  • The great concern are women with SLE and associated pulmonary arterial hypertension who wish to conceive: maternal mortality rates have been quoted as being as high as 33%
  • Women should  be advised not to conceive during a period of active disease, particularly with lupus nephritis, because of worse maternal and fetal outcomes
  • Counsel women with SLE for increased risk of pre-eclampsia, preterm delivery and fetal growth restriction
  • In active lupus nephritis with worsening renal function, increasing proteinuria and hypertension,it may be necessary to use such treatments as cyclophosphamide and mycophenolate mofetil, which are associated with congenital malformations if used in the first trimester,
  • Pregnant women with active SLE/lupus nephritis or anti-Ro/La/antiphospholipidantibodies should be considered as a higher risk group and managed in tertiary centre
  • If severe disease, patients need hospitalisation
  • For patients with stable disease, 4-weekly reviews of disease activity and regular assessment of fetal growth, blood pressure and proteinuria are acceptable.
  • For those women who are anti-Ro/La positive the fetal heart rate should be monitored and recorded at each visit and fetal echocardiography assessments made at 18–20 and ~28 weeks of gestation
  • Women who have had a previous venous thromboembolism  should receive thromboprophylaxis with low molecular weight heparin throughout pregnancy and for 6 weeks postpartum 
  • The risk of an SLE flare in pregnancy is increased with active disease in the 3–6 months prior to conception, with the majority of flares occurring after the 20th weeks of pregnancy
  • Most flares are  managed expectantly with medical management and adjustments to drug therapy
  • At every antenatal visit, measure the BP, test the urine for proteinuria,  and quantify the proteinuria by PCR or 24 hour urine proetien estimation.
  • The features of lupus nephritis include hypertension and proteinuria with or without haematuria and renal impairment
  • The presence of hematuria or red cell casts as well as a rise in anti-dsDNA titres or a fall in complement levels help to distinguish this from pre-eclampsia
  • In cases of lupus nephritis that fail to respond to increasing dosages of steroids and azathioprine, and where there is a deterioration of renal function and/or hypertension, other immunosuppressive drugs may be considered, such as mycophenolate mofetil or tacrolimus. Such management decisions should be undertaken in consultation with nephrologists and rheumatologists.
  • Premature rupture of membranes is also regarded as being more frequent in pregnancies complicated by SLE; rates vary and are generally quoted as ~20% and is common in women who are on steroids
SLE and fetal risks
  • Increased rates of miscarriage,
  • Increased risks of congenital heart block, fetal growth restriction and increased rates of preterm delivery 
  • Scanning at least every 4 weeks to screen for fetal growth restriction in those women at risk is generally accepted and fetal echocardiography referral should be arranged for those with anti-Ro/La antibodies
  • Doppler studies can be used to estimate placental function
  • A uterine artery Doppler should be first carried out at 20 weeks and repeated 4 weeks later if any abnormality is found
  • A raised pulsatility index or diastolic notching are associated with increased risk for developing  pre-eclampsia, as they can indicate underlying placental dysfunction
  • Congenital heart block is associated with maternal anti-Ro/La autoantibodies.
  • usual presentation is a fixed fetal bradycardia of 60–80 beats per minute on ultrasound scan.
  •  It occurs in 2–3% of fetuses of women with the anti-Ro/La antibody 
  • CHB is associated with significant perinatal morbidity and mortality, with about half of infants requiring pacing by the first year of life. 
  • Congenital heart block develops between 18– 28 weeks of gestation and fetal echocardiography should be performed around this period to detect it. Hydrops fetalis can occur in utero and is thought to be due to the degree of endomyocardial fibrosis and associated myocarditis.
Neonatal lupus rash

  • lesions are  commonly seen on the face and scalp 
    and appear typically after ultraviolet exposure in the first 
    2 weeks of life, but can appear  up to 3–6 months postpartum
Drug treatment in SLE

  • Glucocorticoids, mainly in the form of prednisolone, are frequently but not exclusively used as one of the first-line treatments in pregnancy
  • Women on moderate to high dosages of steroids should should be screened regularly for gestational diabetes.
  • Immunosuppressants  that are used and are generally considered safe during pregnancy include azathioprine and hydroxychloroquine. There is no  need to discontinue them during pregnancy
Postpartum management

  • To consider thromboprophylaxis
  • Manage hypertension